ELVN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 25.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $11,949,110.41

Enliven Therapeutics Insider Trading History Chart

Enliven Therapeutics Share Price & Price History

^$28.96

▼ -1.09 (-3.63%)

As of 03/20/2026 04:59 PM ET

Days: 30 | 90 | 365

Enliven Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/6/2026	Benjamin Hohl	CFO	Sell	10,000	$29.58	$295,800.00	51,000
2/17/2026	Richard A. Heyman	Director	Sell	1,230	$26.18	$32,201.40	22,647
2/6/2026	Joseph P. Lyssikatos	Insider	Sell	5,000	$29.04	$145,200.00	740,188
1/20/2026	Joseph P. Lyssikatos	Insider	Sell	20,000	$26.75	$535,000.00	745,188
1/20/2026	Richard A. Heyman	Director	Sell	1,230	$26.75	$32,902.50	23,877
1/9/2026	Anish Patel	COO	Sell	48,300	$27.99	$1,351,917.00	215,011
1/9/2026	Joseph P. Lyssikatos	Insider	Sell	91,198	$27.22	$2,482,409.56	765,188
1/9/2026	Richard A. Heyman	Director	Sell	4,285	$25.00	$107,125.00	25,107
1/8/2026	Joseph P. Lyssikatos	Insider	Sell	41,302	$24.05	$993,313.10	856,386
1/8/2026	Richard A. Heyman	Director	Sell	9,635	$25.03	$241,164.05	25,545
12/19/2025	Joseph P. Lyssikatos	Insider	Sell	5,000	$16.84	$84,200.00	897,688
12/8/2025	Anish Patel	COO	Sell	6,663	$21.02	$140,056.26	263,311
11/19/2025	Joseph P. Lyssikatos	Insider	Sell	12,500	$22.33	$279,125.00	902,688
11/17/2025	Samuel Kintz	CEO	Sell	12,500	$21.82	$272,750.00	890,392
11/7/2025	Anish Patel	COO	Sell	6,667	$17.40	$116,005.80	269,974
10/20/2025	Joseph P. Lyssikatos	Insider	Sell	12,500	$22.08	$276,000.00	915,188
10/17/2025	Samuel Kintz	CEO	Sell	12,500	$21.33	$266,625.00	902,892
10/7/2025	Anish Patel	COO	Sell	6,667	$20.10	$134,006.70	276,641
9/29/2025	Benjamin Hohl	CFO	Sell	3,250	$20.40	$66,300.00	23,000
9/26/2025	Joseph P. Lyssikatos	Insider	Sell	4,000	$20.25	$81,000.00	927,688
9/26/2025	Samuel Kintz	CEO	Sell	3,700	$20.06	$74,222.00	915,392
9/23/2025	Joseph P. Lyssikatos	Insider	Sell	1,500	$20.03	$30,045.00	931,688
9/23/2025	Samuel Kintz	CEO	Sell	2,800	$20.03	$56,084.00	919,092
9/19/2025	Joseph P. Lyssikatos	Insider	Sell	7,000	$19.39	$135,730.00	933,188
9/19/2025	Samuel Kintz	CEO	Sell	1,000	$20.25	$20,250.00	921,892
9/17/2025	Samuel Kintz	CEO	Sell	5,000	$19.09	$95,450.00	922,892
9/8/2025	Anish Patel	COO	Sell	6,667	$20.24	$134,940.08	283,308
8/27/2025	Benjamin Hohl	CFO	Sell	3,250	$20.63	$67,047.50	23,000
8/21/2025	Joseph P. Lyssikatos	Insider	Sell	7,500	$20.01	$150,075.00	940,188
8/19/2025	Joseph P. Lyssikatos	Insider	Sell	5,000	$19.62	$98,100.00	947,688
8/19/2025	Samuel Kintz	CEO	Sell	590	$20.00	$11,800.00	929,409
8/18/2025	Samuel Kintz	CEO	Sell	10,393	$20.02	$208,067.86	929,999
8/7/2025	Anish Patel	COO	Sell	6,667	$18.24	$121,606.08	289,975
7/28/2025	Benjamin Hohl	CFO	Sell	3,250	$20.46	$66,495.00	23,000
7/21/2025	Joseph P. Lyssikatos	Insider	Sell	12,500	$22.29	$278,625.00	952,688
7/17/2025	Samuel Kintz	CEO	Sell	12,500	$22.52	$281,500.00	940,392
7/10/2025	Benjamin Hohl	CFO	Sell	1,000	$22.66	$22,660.00	23,000
7/7/2025	Anish Patel	COO	Sell	6,667	$19.79	$131,939.93	296,642
6/27/2025	Benjamin Hohl	CFO	Sell	3,250	$20.91	$67,957.50	23,000
6/20/2025	Joseph P. Lyssikatos	Insider	Sell	12,500	$21.40	$267,500.00	965,188
6/17/2025	Samuel Kintz	CEO	Sell	12,500	$22.18	$277,250.00	952,892
6/9/2025	Anish Patel	COO	Sell	6,667	$20.34	$135,606.78	303,309
6/3/2025	Joseph P. Lyssikatos	Insider	Sell	7,500	$20.03	$150,225.00	977,688
6/3/2025	Samuel Kintz	CEO	Sell	7,500	$20.05	$150,375.00	965,392
5/27/2025	Benjamin Hohl	CFO	Sell	3,250	$16.18	$52,585.00	23,000
5/19/2025	Joseph P. Lyssikatos	Insider	Sell	5,000	$16.31	$81,550.00	985,188
5/19/2025	Samuel Kintz	CEO	Sell	5,000	$16.49	$82,450.00	972,892
5/7/2025	Anish Patel	COO	Sell	6,667	$18.39	$122,606.13	309,976
5/1/2025	Joseph P. Lyssikatos	Insider	Sell	5,030	$20.07	$100,952.10	992,658
5/1/2025	Samuel Kintz	CEO	Sell	5,330	$20.08	$107,026.40	980,062
4/28/2025	Benjamin Hohl	CFO	Sell	3,250	$18.69	$60,742.50	23,000
4/21/2025	Joseph P. Lyssikatos	Insider	Sell	5,000	$16.07	$80,350.00	997,688
4/17/2025	Samuel Kintz	CEO	Sell	5,000	$16.42	$82,100.00	985,392
4/7/2025	Anish Patel	COO	Sell	6,667	$18.04	$120,272.68	316,643
3/27/2025	Benjamin Hohl	CFO	Sell	3,250	$21.33	$69,322.50	23,000
3/24/2025	Benjamin Hohl	CFO	Sell	1,000	$22.50	$22,500.00	23,000
3/19/2025	Joseph P. Lyssikatos	Insider	Sell	12,500	$20.61	$257,625.00	1,002,688
3/17/2025	Samuel Kintz	CEO	Sell	12,500	$20.83	$260,375.00	990,392
3/7/2025	Anish Patel	COO	Sell	6,667	$21.44	$142,940.48	323,310
2/27/2025	Benjamin Hohl	CFO	Sell	3,250	$20.41	$66,332.50	13,000
2/7/2025	Anish Patel	COO	Sell	6,667	$21.93	$146,207.31	329,977
2/5/2025	Benjamin Hohl	CFO	Sell	1,000	$22.52	$22,520.00	13,000
1/27/2025	Benjamin Hohl	CFO	Sell	3,250	$21.59	$70,167.50	13,000
1/7/2025	Anish Patel	COO	Sell	21,700	$24.18	$524,706.00
1/3/2025	Benjamin Hohl	CFO	Sell	1,000	$25.04	$25,040.00	13,000
12/30/2024	Benjamin Hohl	CFO	Sell	900	$22.51	$20,259.00
12/27/2024	Benjamin Hohl	CFO	Sell	3,350	$22.15	$74,202.50
11/27/2024	Benjamin Hohl	CFO	Sell	5,250	$24.89	$130,672.50
10/28/2024	Benjamin Hohl	CFO	Sell	6,250	$28.56	$178,500.00
10/18/2024	Anish Patel	COO	Sell	716	$30.00	$21,480.00	343,311
10/18/2024	Benjamin Hohl	CFO	Sell	814	$30.00	$24,420.00
10/18/2024	Joseph P. Lyssikatos	Insider	Sell	847	$30.00	$25,410.00	1,015,188
10/18/2024	Richard A. Heyman	Director	Sell	817	$30.00	$24,510.00	123,673
10/18/2024	Samuel Kintz	CEO	Sell	924	$30.00	$27,720.00	1,002,892
10/15/2024	Richard A. Heyman	Director	Sell	1,270	$27.67	$35,140.90	124,490
10/9/2024	Joseph P. Lyssikatos	Insider	Sell	37,878	$28.16	$1,066,644.48	1,016,035
10/9/2024	Samuel Kintz	CEO	Sell	16,710	$28.15	$470,386.50	1,003,816
10/8/2024	Rahul D. Ballal	Director	Sell	10,420	$28.17	$293,531.40	22,341
10/7/2024	Benjamin Hohl	CFO	Sell	1,270	$27.51	$34,937.70
10/7/2024	Joseph P. Lyssikatos	Insider	Sell	2,707	$27.61	$74,740.27	1,067,180
10/7/2024	Samuel Kintz	CEO	Sell	2,730	$27.50	$75,075.00	1,033,793
10/4/2024	Benjamin Hohl	CFO	Sell	10,218	$27.51	$281,097.18
10/4/2024	Joseph P. Lyssikatos	Insider	Sell	7,522	$27.51	$206,930.22	1,069,887
10/4/2024	Richard A. Heyman	Director	Sell	2,825	$27.51	$77,715.75	125,760
10/4/2024	Samuel Kintz	CEO	Sell	12,206	$27.51	$335,787.06	1,036,523
10/1/2024	Joseph P. Lyssikatos	Insider	Sell	527	$27.54	$14,513.58	1,077,409
10/1/2024	Richard A. Heyman	Director	Sell	518	$27.54	$14,265.72	128,585
10/1/2024	Samuel Kintz	CEO	Sell	526	$27.54	$14,486.04	1,048,729
9/30/2024	Benjamin Hohl	CFO	Sell	2,000	$25.33	$50,660.00
9/27/2024	Benjamin Hohl	CFO	Sell	4,250	$24.27	$103,147.50
8/29/2024	Joseph P. Lyssikatos	Insider	Sell	12,000	$22.49	$269,880.00	1,077,936
8/27/2024	Benjamin Hohl	CFO	Sell	4,250	$22.54	$95,795.00
8/26/2024	Samuel Kintz	CEO	Sell	12,000	$22.89	$274,680.00	1,049,255
8/15/2024	Richard A. Heyman	Director	Sell	1,270	$23.25	$29,527.50	130,373
7/31/2024	Benjamin Hohl	CFO	Sell	991	$27.53	$27,282.23
7/31/2024	Joseph P. Lyssikatos	Insider	Sell	3,099	$27.56	$85,408.44	1,089,936
7/31/2024	Richard A. Heyman	Director	Sell	1,702	$27.51	$46,822.02	131,643
7/31/2024	Samuel Kintz	CEO	Sell	2,270	$27.56	$62,561.20	1,061,255
7/29/2024	Benjamin Hohl	CFO	Sell	5,250	$26.68	$140,070.00
7/29/2024	Joseph P. Lyssikatos	Insider	Sell	12,000	$26.70	$320,400.00	1,093,035
7/25/2024	Samuel Kintz	CEO	Sell	12,000	$24.92	$299,040.00	1,063,525
7/15/2024	Anish Patel	COO	Sell	30,978	$25.05	$775,998.90	345,574
7/15/2024	Richard A. Heyman	Director	Sell	1,270	$24.80	$31,496.00	133,345
7/12/2024	Anish Patel	COO	Sell	17,475	$25.07	$438,098.25	376,552
7/12/2024	Benjamin Hohl	CFO	Sell	3,000	$25.07	$75,210.00
6/27/2024	Benjamin Hohl	CFO	Sell	4,250	$22.57	$95,922.50
6/25/2024	Samuel Kintz	CEO	Sell	12,000	$21.66	$259,920.00	1,075,525
6/6/2024	Anish Patel	COO	Sell	1,133	$20.06	$22,727.98
5/28/2024	Benjamin Hohl	CFO	Sell	4,250	$23.18	$98,515.00
5/28/2024	Samuel Kintz	CEO	Sell	12,000	$23.18	$278,160.00
5/16/2024	Rishi Gupta	Director	Sell	1,033,300	$22.14	$22,877,262.00	254,814
5/14/2024	Anish Patel	COO	Sell	1,107	$25.00	$27,675.00
5/9/2024	Anish Patel	COO	Sell	260	$25.06	$6,515.60
5/6/2024	Anish Patel	COO	Sell	4,875	$22.72	$110,760.00
5/3/2024	Benjamin Hohl	CFO	Sell	1,000	$22.50	$22,500.00
4/29/2024	Benjamin Hohl	CFO	Sell	3,250	$16.97	$55,152.50
4/29/2024	Joseph P. Lyssikatos	insider	Sell	12,000	$17.92	$215,040.00
4/25/2024	Samuel Kintz	CEO	Sell	12,000	$16.89	$202,680.00
4/15/2024	Richard A. Heyman	Director	Sell	1,270	$19.99	$25,387.30	137,155
4/11/2024	Anish Patel	COO	Sell	17,500	$25.03	$438,025.00
4/11/2024	Benjamin Hohl	CFO	Sell	14,000	$24.72	$346,080.00
4/11/2024	Joseph P. Lyssikatos	insider	Sell	30,000	$25.04	$751,200.00
4/11/2024	Rahul D. Ballal	Director	Sell	53,400	$23.95	$1,278,930.00	22,341
4/11/2024	Samuel Kintz	CEO	Sell	47,709	$25.04	$1,194,633.36
4/8/2024	Anish Patel	COO	Sell	4,875	$18.60	$90,675.00	2,597
4/4/2024	Rahul D. Ballal	Director	Sell	3,485	$19.15	$66,737.75	22,341
4/1/2024	Joseph P. Lyssikatos	insider	Sell	12,000	$18.60	$223,200.00
4/1/2024	Rahul D. Ballal	Director	Sell	3,237	$19.08	$61,761.96	22,341
3/27/2024	Benjamin Hohl	CFO	Sell	3,250	$18.25	$59,312.50
3/25/2024	Samuel Kintz	CEO	Sell	12,000	$17.56	$210,720.00
3/19/2024	Richard A. Heyman	Director	Sell	1,270	$14.50	$18,415.00	143,470
3/6/2024	Anish Patel	COO	Sell	4,875	$15.64	$76,245.00	7,472
2/29/2024	Joseph P. Lyssikatos	insider	Sell	12,000	$16.42	$197,040.00
2/27/2024	Benjamin Hohl	CFO	Sell	3,250	$16.97	$55,152.50
2/15/2024	Richard A. Heyman	Director	Sell	1,270	$17.42	$22,123.40	144,740
2/6/2024	Anish Patel	COO	Sell	4,875	$15.11	$73,661.25	12,347
1/31/2024	5Am Partners Vi, Llc	Major Shareholder	Sell	500,000	$15.00	$7,500,000.00	771,983
1/30/2024	Richard A. Heyman	Director	Sell	1,270	$16.41	$20,840.70	146,010
1/29/2024	Benjamin Hohl	CFO	Sell	3,250	$15.81	$51,382.50
1/29/2024	Joseph P. Lyssikatos	insider	Sell	12,000	$15.85	$190,200.00
1/25/2024	Samuel Kintz	CEO	Sell	12,000	$15.69	$188,280.00
1/22/2024	Anish Patel	COO	Sell	4,875	$15.13	$73,758.75	17,222
1/2/2024	Anish Patel	COO	Sell	11,000	$15.00	$165,000.00	22,097
1/2/2024	Benjamin Hohl	CFO	Sell	9,383	$15.01	$140,838.83
12/26/2023	Anish Patel	COO	Sell	102	$15.01	$1,531.02	35,637
12/26/2023	Benjamin Hohl	CFO	Sell	100	$15.00	$1,500.00
12/26/2023	Samuel Kintz	CEO	Sell	12,000	$14.64	$175,680.00
12/22/2023	Anish Patel	COO	Sell	983	$15.03	$14,774.49	35,739
12/22/2023	Benjamin Hohl	CFO	Sell	1,030	$15.07	$15,522.10
12/22/2023	Samuel Kintz	CEO	Sell	8,175	$13.05	$106,683.75
12/21/2023	Joseph P. Lyssikatos	insider	Sell	20	$13.00	$260.00
12/21/2023	Richard A. Heyman	Director	Sell	7	$13.00	$91.00	147,448
12/20/2023	Samuel Kintz	CEO	Sell	7,779	$13.01	$101,204.79
12/19/2023	Joseph P. Lyssikatos	insider	Sell	200	$13.00	$2,600.00
12/19/2023	Richard A. Heyman	Director	Sell	255	$13.00	$3,315.00	149,565
11/3/2023	Joseph P. Lyssikatos	insider	Sell	8,546	$13.08	$111,781.68
11/3/2023	Samuel Kintz	CEO	Sell	8,026	$13.08	$104,980.08
9/29/2023	Joseph P. Lyssikatos	insider	Sell	12,000	$13.62	$163,440.00
9/26/2023	5Am Partners Vi, Llc	Major Shareholder	Sell	197,500	$15.00	$2,962,500.00	854,796
9/25/2023	Samuel Kintz	CEO	Sell	12,000	$13.81	$165,720.00
8/24/2023	5Am Partners Vi, Llc	Major Shareholder	Sell	440,000	$16.00	$7,040,000.00	887,507

SEC Filings (Institutional Ownership Changes) for Enliven Therapeutics (NASDAQ:ELVN)

95.08% of Enliven Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Enliven Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/26/2026	Seven Fleet Capital Management LP	11,688	$0.18M	0.1%	N/A	0.020%
2/19/2026	Invesco Ltd.	24,720	$0.38M	0.0%	+7.0%	0.042%
2/18/2026	XTX Topco Ltd	60,702	$0.94M	0.0%	+472.6%	0.102%
2/18/2026	Vestal Point Capital LP	3,830,000	$58.98M	2.0%	+230.2%	6.454%
2/18/2026	Virtus Investment Advisers LLC	15,778	$0.24M	0.1%	+172.6%	0.027%
2/18/2026	Wellington Management Group LLP	129,876	$2M	0.0%	+19.6%	0.219%
2/18/2026	Susquehanna Portfolio Strategies LLC	48,741	$0.75M	0.0%	+53.6%	0.082%
2/18/2026	Tudor Investment Corp ET AL	29,673	$0.46M	0.0%	+82.0%	0.050%
2/18/2026	Sphera Funds Management LTD.	226,765	$3.49M	0.7%	+36.0%	0.382%
2/18/2026	Millennium Management LLC	296,947	$4.57M	0.0%	-22.1%	0.500%
2/18/2026	Janus Henderson Group PLC	1,671,724	$25.75M	0.0%	-6.8%	2.817%
2/18/2026	Baker BROS. Advisors LP	271,406	$4.18M	0.0%	+136.3%	0.457%
2/17/2026	ADAR1 Capital Management LLC	30,000	$0.46M	0.0%	N/A	0.051%
2/17/2026	Jump Financial LLC	45,354	$0.70M	0.0%	N/A	0.076%
2/17/2026	Price T Rowe Associates Inc. MD	23,800	$0.37M	0.0%	-89.7%	0.040%
2/17/2026	Rock Springs Capital Management LP	798,405	$12.30M	0.6%	+16.4%	1.345%
2/17/2026	California State Teachers Retirement System	32,206	$0.50M	0.0%	+58.4%	0.054%
2/17/2026	Russell Investments Group Ltd.	3,121	$48K	0.0%	-14.3%	0.005%
2/17/2026	State of Wisconsin Investment Board	20,398	$0.31M	0.0%	-57.2%	0.034%
2/17/2026	ExodusPoint Capital Management LP	60,415	$0.93M	0.0%	+25.5%	0.102%
2/17/2026	Polar Capital Holdings Plc	3,513,680	$54.11M	0.2%	+13.5%	5.920%
2/16/2026	Squarepoint Ops LLC	20,763	$0.32M	0.0%	-42.1%	0.035%
2/16/2026	Spruce Street Capital LP	446,084	$6.87M	2.3%	N/A	0.752%
2/16/2026	Barclays PLC	69,875	$1.08M	0.0%	-1.2%	0.118%
2/13/2026	Marshall Wace LLP	371,906	$5.73M	0.0%	+9.2%	0.627%
2/13/2026	The Manufacturers Life Insurance Company	19,336	$0.30M	0.0%	-56.1%	0.033%
2/13/2026	Exome Asset Management LLC	222,308	$3.42M	1.6%	N/A	0.375%
2/13/2026	Charles Schwab Investment Management Inc.	355,192	$5.47M	0.0%	-2.2%	0.598%
2/13/2026	State Street Corp	1,052,862	$16.21M	0.0%	+9.1%	1.774%
2/13/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	55,210	$0.85M	0.0%	+6.8%	0.093%
2/13/2026	Wells Fargo & Company MN	43,056	$0.66M	0.0%	+66.7%	0.073%
2/12/2026	Dimensional Fund Advisors LP	398,893	$6.14M	0.0%	+148.6%	0.672%
2/12/2026	Patient Square Capital LP	308,141	$4.75M	1.0%	+22.8%	0.519%
2/12/2026	New York State Common Retirement Fund	9,097	$0.14M	0.0%	-39.7%	0.015%
2/12/2026	Swiss National Bank	64,273	$0.99M	0.0%	+1.7%	0.108%
2/12/2026	Nuveen LLC	105,448	$1.62M	0.0%	-2.6%	0.178%
2/11/2026	Deutsche Bank AG	31,420	$0.48M	0.0%	+24.7%	0.053%
2/11/2026	Fox Run Management L.L.C.	12,432	$0.19M	0.0%	N/A	0.021%
2/11/2026	Franklin Resources Inc.	20,167	$0.31M	0.0%	-95.3%	0.034%
2/11/2026	Capital Research Global Investors	1,304,346	$20.09M	0.0%	-0.8%	2.198%
2/11/2026	Los Angeles Capital Management LLC	5,409	$83K	0.0%	N/A	0.009%
2/10/2026	Goldman Sachs Group Inc.	237,204	$3.65M	0.0%	-9.6%	0.400%
2/10/2026	AXQ Capital LP	14,244	$0.22M	0.0%	N/A	0.024%
2/10/2026	Intech Investment Management LLC	16,729	$0.26M	0.0%	+15.6%	0.028%
2/9/2026	Geode Capital Management LLC	1,048,722	$16.15M	0.0%	-3.3%	1.767%
1/29/2026	Pictet Asset Management Holding SA	1,303,235	$20.07M	0.0%	-6.8%	2.196%
1/29/2026	China Universal Asset Management Co. Ltd.	9,671	$0.15M	0.0%	-6.9%	0.016%
1/27/2026	Zurcher Kantonalbank Zurich Cantonalbank	6,163	$95K	0.0%	N/A	0.010%
1/26/2026	Mirae Asset Global Investments Co. Ltd.	2,884	$44K	0.0%	+25.9%	0.005%
1/9/2026	SG Americas Securities LLC	14,035	$0.22M	0.0%	-36.9%	0.024%
1/1/2026	JPMorgan Chase & Co.	24,818	$0.51M	0.0%	+30.2%	0.042%
1/1/2026	Tudor Investment Corp ET AL	16,303	$0.33M	0.0%	N/A	0.027%
12/9/2025	Tudor Investment Corp ET AL	16,303	$0.33M	0.0%	N/A	0.027%
11/17/2025	Woodline Partners LP	300,499	$6.15M	0.0%	-72.7%	0.506%
11/17/2025	Vestal Point Capital LP	1,160,000	$23.75M	1.1%	+364.0%	1.955%
11/17/2025	Polar Capital Holdings Plc	3,095,007	$63.36M	0.3%	+1.5%	5.215%
11/17/2025	Millennium Management LLC	381,405	$7.81M	0.0%	+19.8%	0.643%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	19,529	$0.40M	0.0%	+10.6%	0.033%
11/17/2025	HighVista Strategies LLC	259,135	$5.30M	1.3%	+83.1%	0.437%
11/17/2025	Citadel Advisors LLC	1,160,503	$23.76M	0.0%	-21.1%	1.955%
11/17/2025	Bank of America Corp DE	23,543	$0.48M	0.0%	-3.9%	0.040%
11/17/2025	Ameriprise Financial Inc.	123,336	$2.53M	0.0%	+108.2%	0.208%
11/14/2025	Man Group plc	13,371	$0.27M	0.0%	N/A	0.023%
11/14/2025	Duquesne Family Office LLC	947,405	$19.39M	0.5%	+104.6%	1.599%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	51,683	$1.06M	0.0%	-37.8%	0.087%
11/14/2025	Squarepoint Ops LLC	35,845	$0.73M	0.0%	N/A	0.061%
11/13/2025	Marshall Wace LLP	340,482	$6.97M	0.0%	+2.1%	0.575%
11/13/2025	Landscape Capital Management L.L.C.	10,301	$0.21M	0.0%	N/A	0.017%
11/13/2025	UBS Group AG	79,508	$1.63M	0.0%	-42.5%	0.134%
11/13/2025	BNP Paribas Financial Markets	9,144	$0.19M	0.0%	+145.7%	0.015%
11/13/2025	Legal & General Group Plc	33,765	$0.69M	0.0%	+4.8%	0.057%
11/13/2025	WINTON GROUP Ltd	16,458	$0.34M	0.0%	N/A	0.028%
11/13/2025	Russell Investments Group Ltd.	3,642	$75K	0.0%	-87.7%	0.006%
11/12/2025	Barclays PLC	70,689	$1.45M	0.0%	-2.9%	0.119%
11/12/2025	Dimensional Fund Advisors LP	160,459	$3.28M	0.0%	+242.5%	0.271%
11/12/2025	Quantbot Technologies LP	2,146	$44K	0.0%	-52.1%	0.004%
11/10/2025	TD Asset Management Inc	27,518	$0.56M	0.0%	-58.9%	0.046%
11/10/2025	Patient Square Capital LP	250,838	$5.14M	1.4%	+2.0%	0.423%
11/7/2025	NEOS Investment Management LLC	40,314	$0.83M	0.0%	+23.7%	0.068%
11/7/2025	Vanguard Group Inc.	2,553,014	$52.26M	0.0%	+5.9%	4.310%
11/7/2025	JPMorgan Chase & Co.	24,818	$0.51M	0.0%	+30.2%	0.042%
11/6/2025	Rhumbline Advisers	60,160	$1.23M	0.0%	+19.6%	0.102%
11/6/2025	Candriam S.C.A.	609,352	$12.47M	0.1%	+46.3%	1.029%
11/3/2025	AlphaQuest LLC	4,701	$96K	0.0%	N/A	0.008%
11/3/2025	New York State Common Retirement Fund	15,097	$0.31M	0.0%	+54.1%	0.025%
11/3/2025	Federated Hermes Inc.	10,811	$0.22M	0.0%	-32.8%	0.018%
10/23/2025	SG Americas Securities LLC	22,242	$0.46M	0.0%	-38.9%	0.038%
8/15/2025	Tower Research Capital LLC TRC	5,286	$0.11M	0.0%	+194.3%	0.009%
8/15/2025	Duquesne Family Office LLC	463,000	$9.29M	0.2%	N/A	0.782%
8/15/2025	BNP Paribas Financial Markets	3,722	$75K	0.0%	+33.3%	0.008%
8/15/2025	Bank of America Corp DE	24,508	$0.49M	0.0%	+20.0%	0.050%
8/15/2025	5AM Venture Management LLC	772,477	$15.50M	6.0%	-41.6%	1.574%
8/15/2025	Adage Capital Partners GP L.L.C.	96,000	$1.93M	0.0%	-78.7%	0.196%
8/15/2025	Ameriprise Financial Inc.	59,244	$1.19M	0.0%	+150.4%	0.121%
8/14/2025	Commodore Capital LP	4,692,809	$94.14M	6.6%	+0.4%	9.563%
8/14/2025	TCG Crossover Management LLC	498,000	$9.99M	1.1%	N/A	1.015%
8/14/2025	Jane Street Group LLC	56,981	$1.14M	0.0%	+94.1%	0.116%
8/14/2025	California State Teachers Retirement System	20,330	$0.41M	0.0%	-2.8%	0.041%
8/14/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	17,656	$0.35M	0.0%	-18.7%	0.036%
8/14/2025	The Manufacturers Life Insurance Company	44,151	$0.89M	0.0%	+242.4%	0.090%

Data available starting January 2016

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations. The company is headquartered in Boulder, Colorado.

Today's Range

Now: $28.96

$28.62

$30.34

50 Day Range

MA: $27.63

$25.03

$30.68

52 Week Range

Now: $28.96

$13.30

$31.75

Volume

862,452 shs

Average Volume

997,457 shs

Market Capitalization

$1.73 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.33

Who are the company insiders with the largest holdings of Enliven Therapeutics?: Enliven Therapeutics' top insider investors include:
Joseph P Lyssikatos (Insider)
Samuel Kintz (CEO)
Anish Patel (COO)
Rishi Gupta (Director)
Richard A Heyman (Director)
Benjamin Hohl (CFO)
Rahul D Ballal (Director)
Joseph P Lyssikatos (Insider)
Learn More about top insider investors at Enliven Therapeutics.
Who are the major institutional investors of Enliven Therapeutics?: Enliven Therapeutics' top institutional shareholders include:
Vestal Point Capital LP — 6.45%
Polar Capital Holdings Plc — 5.92%
Janus Henderson Group PLC — 2.82%
Capital Research Global Investors — 2.20%
Pictet Asset Management Holding SA — 2.20%
State Street Corp — 1.77%
Learn More about top institutional investors of Enliven Therapeutics stock.
Which institutional investors are selling Enliven Therapeutics stock?: Within the previous quarter, ELVN stock was sold by these institutional investors:
Franklin Resources Inc.
Price T Rowe Associates Inc. MD
Janus Henderson Group PLC
Pictet Asset Management Holding SA
Millennium Management LLC
Geode Capital Management LLC
State of Wisconsin Investment Board
Goldman Sachs Group Inc.
In the previous year, company insiders that have sold Enliven Therapeutics company stock include:
Joseph P Lyssikatos (Insider)
Samuel Kintz (CEO)
Anish Patel (COO)
Rishi Gupta (Director)
Richard A Heyman (Director)
Learn More investors selling Enliven Therapeutics stock.
Which institutional investors are buying Enliven Therapeutics stock?: During the previous quarter, ELVN stock was acquired by institutional investors including:
Vestal Point Capital LP
Spruce Street Capital LP
Polar Capital Holdings Plc
Dimensional Fund Advisors LP
Exome Asset Management LLC
Baker BROS. Advisors LP
Rock Springs Capital Management LP
State Street Corp